James R. Kasinger, General Counsel and Secretary at CRISPR Therapeutics AG (CRSP), sold 23,084 shares at $52.80 ($1.2M) on 2025-02-19, disclosed to the SEC on 2025-02-19.
Open-market sale of $1.2M CRSP by General Counsel and Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.85 | 9,595 | $517K | 41.7% |
| 2 | $53.85 | 9,595 | $517K | 41.7% |
| 3 | $52.80 | 1,947 | $103K | 8.3% |
| 4 | $52.80 | 1,947 | $103K | 8.3% |
| Total | $53.67 avg | 23,084 | $1.2M | 100% |
| Filing → |
| CRSP | SELL | 2026-03-24 | $149K | — | Filing → |
| CRSP | SELL | 2026-03-17 | $166K | — | Filing → |
| CRSP | SELL | 2026-03-12 | $148K | — | Filing → |